Office of Professional Education

Respiratory Medicine Updates: A Virtual Clinical Community 

Our Next Session is February 8-9, 2022 • CME Credit for Zoom Webinar and Twitter Chat participants

Article: Leukocyte Telomere Length and Mycophenolate Therapy in Chronic Hypersensitivity Pneumonitis. Eur Respir J. 2021 Mar 4;57(3):2002872. doi: 10.1183/13993003.02872-2020. Print 2021 Mar.
  • Zoom Webinar with CME credit: REGISTER.
    • Tuesday, February 8, 2022
    • 11:30 am (PT) / 12:30 pm (MT) / 1:30 pm (CT) / 2:30 pm (ET)
    • 30-minutes
    • Expert faculty summarize a journal article and lead an academic and peer discussion with Q&A time.
  • Twitter Chat @NJHealthMedEd with CME credit: Add to Calendar
    • Wednesday, February 9, 2022
    • 6:00 pm (PT) / 7:00 pm (MT) / 8:00 pm (CT) / 9:00 pm (ET)
    • 30-minutes
    • Expert faculty lead the Chat about the article summary to facilitate an academic and peer discussion with Q&A.
    • Go to Twitter, type in #ILDTwitterJC and click on the “Latest” tab
    • Please use this hashtag when posting: #ILDTwitterJC
    • Twitter Chat Instructions
    • Follow us on Twitter @NJHealthMedEd

Previous ILD Journal Club Sessions:

  • December 14-15, 2021
    • December 2021 Article Summary: Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med 2019; 381:1718-1727 DOI: 10.1056/NEJMoa1908681. View here.
    • Recorded Zoom Webinar on VuMedi.
 
  • November 9-10, 2021
    • November 2021 Article Summary: Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med 2021;384:599-609. DOI: 10.1056/NEJMoa2023386. View here.
    • Recorded Zoom Webinar on VuMedi.
 
  • October 12-13, 2021
    • October 2021 Article Summary: Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. Am J Respir Crit Care Med. 2021 Jan 15;203(2):211-220. doi: 10.1164/rccm.202003-0877OC. View here.
    • Recorded Zoom Webinar on VuMedi.
 
  • September 14, 2021
    • September 2021 Article Summary: Tocilizumab in systemic sclerosis: a randomized, double-blind, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. View here.
    • Recorded Zoom Webinar on VuMedi.
 
  • August 10-11, 2021
    • August 2021 Article Summary: Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomized controlled trial, The Lancet Respiratory Medicine. 2018;6(10):759-770. View here.
    • Recorded Zoom Webinar on VuMedi.

Target Audience:

Pulmonologists, Rheumatologists, Radiologists, Pathologists, Dermatologists, Primary Care Physicians, Physician Assistants, and Nurse Practitioners.

 

Program Chair:

Matthew Koslow MD

Matthew Koslow, MD
Assistant Professor
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health, Denver, CO

 

Learning Objectives:

Upon completion of this activity, the participant will be better able to:

  • Apply critical thinking and research analysis in the review of research and guidelines in ILD
  • Utilize increased awareness and understanding of research, evidence and best practices to inform clinical practice in ILD
  • Support an online community of practitioners to share key insights, latest research, and treatment strategies for patients with ILD

 

Contact:

For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email proed@njhealth.org.

 

Accreditation and Designation Statements:

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Webinars
National Jewish Health designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Twitter Chat Sessions
National Jewish Health designates each Other activity (social media discussion) for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Support:

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.